Prof. Isaac F. ADEWOLE

Basic Information

	Name: Prof. Issac F. Adewole	Faculty: CLINICAL SCIENCES
	Email: This email address is being protected from spambots. You need JavaScript enabled to view it.	Department:Obstetrics and Gynaecology
	Designation: Professor
Brief Biography:

`Resume`

Isaac F. ADEWOLE

Address:

Gynaecologic Oncology Unit,

Department of Obstetrics and Gynaecology,

College of Medicine, University of Ibadan, Ibadan, Nigeria.

Tel: 0803.329.9153 & 0805.506.3598

e-mail:This email address is being protected from spambots. You need JavaScript enabled to view it., This email address is being protected from spambots. You need JavaScript enabled to view it.

Institutions Attended (with dates)

Ilesha Grammar School, Ilesha (1966-1972)

University of Ibadan, Ibadan. (October 1973-June 1978)

Academic Qualification (with dates and granting bodies)

West African School Certificate (O/L),

Division One With Distinction (1970)

Higher School Certificate (A/L), (1972). AAC.

University of Ibadan, Ibadan. MB;BS June 1978.

University Education (with date)

October 1973 - June 1978: University of Ibadan, Ibadan.

Professional Qualifications and Diplomas

Fellow, National Postgraduate Medical College of Nigeria, (FMCOG). May 1986

Fellow, West African College of Surgeons (FWACS). January 1994

Fellow Nigerian Academy of Science (FAS) January, 2011

Scholarships, Fellowships and Prizes

Bixby Leadership Fellow, Guttmacher Institute, USA -2008

Federal Government of Nigeria Postgraduate Scholarship Award 1981 (For Postgraduate Study in Obstetrics & Gynaecology.

Fellowship, West African College of Surgeons 1981

National Award Scholar, University of Ibadan 1973-1978 (Undergraduate)

Glazo Allenbury Prize for the best overall performance in Paediatrics - 1978

Current Position

Vice-Chancellor, University of Ibadan, Ibadan. 01 December, 2010 – date.

University Working Experience (with dates)

Adjunct Professor, Northwestern University, Chicago, Illinois, USA – May 1^st, 2010 – date

Professor, College Of Medicine, University of Ibadan – October 1^st, 1997 – date.

Provost, College of Medicine, University College Hospital, Ibadan, Nigeria – August 01, 2002 – July 31^st, 2006.

Dean, Faculty of Clinical Sciences & Dentistry – August 01, 2000 – July 31, 2002.

Acting Head, Department of Obstetrics/Gynaecology, University of Ibadan – 1999-2000.

Senior Lecturer, College Of Medicine, University of Ibadan – 1992 – 1997.

Lecturer 1, College Of Medicine, University of Ibadan – 1989 – 1992.

Hospital Working Experience

Consultant Obstetrician/Gynaecologist, UCH – March 22, 1989 – date.

Consultant Obstetrician/Gynaecologist, Royal Crown Specialist Hospital, Ibadan – 1985 – 1989.

Research Fellow – Department of Medical Oncology, Charring Cross Hospital, London – 1985 – 1986.

Senior Registrar, Dept. of Obstetrics & Gynaecology, University College Hospital Ibadan – 1984 – 1985.

Registrar, Dept. of Obstetrics & Gynaecology, University College Hospital, Ibadan – 1982 – 1984.

Senior House-Officer, Dept. of Obstetrics & Gynaecology, University College Hospital, Ibadan – 1981 – 1982.

Medical Officer, Adeoyo Maternity Hospital, Ibadan, Nigeria – 1980 – 1981.

National Youth Service Corps-General Hospital, Sokoto, Nigeria – 1979 - 1980.

House-Officer, University College Hospital, Ibadan, Nigeria – 1978 -1979.

University Administrative Experience

Member - Governing Council, University of Ibadan - 2007- till date.

Member (In attendance) Council – Governing Council, University of Ibadan – 2002-2006.

Member, MacArthur Grant Implementation Committee, University of Ibadan – 2002-2006.

Member (In attendance) Principal Officers Meeting – University of Ibadan - 2002-2006.

Member of Senate, University of Ibadan – 1997 till date.

Member, Committee of Provost and Deans - University of Ibadan, Ibadan - 2000-2006.

Chairman, University Campus Committee of AIDS – 2003-2006.

Chairman, Committee on Evaluation of Academic Staff - 2004.

Member, Committee on Review of Guidelines for Promotion of Academic Staff – University of Ibadan - 2001/2002.

Member of the Organizing Committee of NUGA - 2002.

Chairman, Medical Subcommittee - NUGA 2002.

Project Director: UNFPA Assisted Programme on Sexual and Reproductive Health and HIV Prevention, University of Ibadan -2006 till date.

Management Experience – National and International

Member, Governing Council, Association of Commonwealth Universities(ACU), London 2013-2015

Member, Cancer Ethics Committee( IEC) ,International Agency for Research on Cancer (IARC) 2013-2015

Immediate Past-President, African Organization for Research and Training in Cancer (AORTIC) 2011-2013.

President-Elect, African Organization for Research and Training in Cancer (AORTIC) 2009-2011.

Chair - Prevention of Mother to Child Transmission (PMTCT) of HIV National Task Team-February 2010 – June 2011.

Visiting Scholar - Guttmacher Institute, New York, USA 13^th Oct – 7^th Nov 2008

Member Independent Data Monitoring Committee (IDMC) -HPV-019/020/021 International Studies in Senegal, Tanzania and South Africa- 2008 till date

Chair- National Panel on Cervical Cancer Control Policy- July 2009 till date.

Chairman, PMTCT National Task Team, sub-committee on Research - March 29, 2004 –June 2011.

Member, Ethical, Legal and Social Implication (ELSI) Group, The International HapMap Consortium - Jan 2004 till 2006.

Member, Cancer sub-committee of the National Expert Committee on Non-Communicable Diseases. – July, 2003 till date.

Chairman, PMTCT National Task Team Sub-committee on Anti-retroviral for the Prevention of Mother to Child Transmission of HIV - May, 2003 –June 2011.

Member, National Task-force on Prevention of Mother to Child Transmission (PMTCT) of HIV - 2001 –June 2011.

Director, Prevention of PMTCT of HIV Project, College of Medicine, University College Hospital, Ibadan.

Principal Investigator: APIN Plus PEPFAR Program- University College Hospital, Ibadan.

Country-PI Operation Stop Cervical Cancer in Nigeria – 2006 till date.

Chairman, Sub-Saharan Africa Cervical Cancer Working Group - 14 December,2007 till date

Member, Medical Practitioner Disciplinary Tribunal – April 2004-2006.

Member, Education Committee, Medical and Dental Council of Nigeria – 2002-2006.

Member, Medical and Dental Council of Nigeria – 2002-2006.

Secretary, African Regional Task-force on the Control of Gynaecological Cancers.

Secretary-General - Confederation of African Medical Associations and Societies (CAMAS) - August 1997-2003.

Assistant Secretary-General - Confederation of African Medical Associations and Societies (CAMAS). March 1992 - August 1997.

Chairman - Nigerian Medical Association (Oyo State Branch) - 1993-1995.

Member - National Task Force on Appropriate use of blood and blood products - 1992.

Member - Joint Committee NMA - National Task Force on HIV/AIDS - 1992.

Secretary - NMA AIDS Committee - 1990-1992.

Secretary-General, Nigerian Medical Association - 1990-1992.

Deputy Secretary-General, Nigerian Medical Association - 1988-1990.

Member, NMA Visitation Team on Study of Swedish Health Care System – 1984.

Member, NMA Committee on National Health Policy - 1984.

Member, NMA Negotiating Panel on Residency Training Programme - 1983-1984.

Secretary, Nigerian Medical Association (Oyo State Branch) - 1984 – 1985.

President, National Association of Resident Doctors of Nigeria (NARD) - 1983-1984.

Secretary-General, Association of Resident Doctors, University College Hospital, Ibadan Nigeria - 1982-1983.

Member, Editorial Board – The Global Santé Journal

Nigerian Journal of Medicine - 1997 - till date.

Editorial Adviser: Nigerian Medical Journal - 1989-1992.

Consultant, National Tumour marker Project - 1997 till date.

Honours and Awards

Best Head of Department-College of Medicine, University of Ibadan. 1999/2000.

Best Lecturer of the Year Award- College of Medicine, University of Ibadan November 1995.

Brownite of Honour - Alexander Brown Hall, University of Ibadan - November 1994.

Membership of Learned Societies

Member, Nigerian Medical Association.

Member, Confederation of African Medical Associations and Societies (CAMAS).

Member, Society of Gynaecology & Obstetrics of Nigeria (SOGON).

Member, American Association for the Advancement of Science.

Member, Nigerian Society for the Study of Pain

Member, Cancer Palliative Care Group, Ibadan. Nigeria.

Member, African Organization for Research and Training in Cancer (AORTIC) 2009-2011.

Member, International Society for Gynaecologic Endoscopy.

Member, International Network on Control of Gynaecological Cancers.

Member, International AIDS Society

Member, International Society for Infectious Diseases

Member, Association of Clinical Oncologist, USA

International Fellow, Association of Professors of Gynaecology &Obstetrics, USA.

Trainer in PMTCT – Family Health International (FHI) - 2002 till date

Trainer in PMTCT- UNICEF - 2004

Details of Teaching Experience at University Level

Teaching undergraduate medical students in Obstetrics and Gynaecology 1981 - 1985 while undergoing residency training.

Teaching of undergraduate students since appointment as Lecturer I in 1989 till date.

Teaching of postgraduate students enrolled in fellowship programme of National postgraduate medical college and West African College of Surgeons since 1989.

As External Examiner in Obstetrics & Gynaecology

I have been External Examiner in Obstetrics and Gynaecology to the following Universities

(i) Obafemi Awolowo University, Ile-Ife (1995)

(ii) Ahmadu Bello University Zaria (1996 till date).

(iii) Ogun State University, Sagamu (1997)

(iv) Othman Dan Fodio University, Sokoto (1997-1999)

(v) University of Ilorin, Ilorin. (2000)

(vi) University of Lagos (2009)

(vii) University of Jos (2010)

Primary Fellowship Examination of the National Postgraduate Medical College. (1992 - 1996).

Part 1/2 Fellowship Examination of the National Postgraduate Medical College -2000 till date

Part 1/2 Fellowship Examination of the West African College of Surgeon. -1999 till date

Scientific Conferences/Workshops Attended

1. 2nd Congress of Confederation of African Medical Associations and Societies (CAMAS) on The Role of the Health Centre on Primary Health Care in Africa: Cairo Egypt. 13--19 September, 1984.

2. Certificate Course in Endoscopy, Management of Problems of Infertility and Family Planning John Hopkins Program on International Education in Gynaecology and Obstetrics (JHPIEGO), University College Hospital, Ibadan. November 1984.

3. Growth Areas in Oncology. The British Council Course 547 Charring Cross Hospital, London. June, 1985.

4. 7th Congress of Confederation of African Medical Association and Societies (CAMAS) on HIV and AIDs in Africa. Addis Ababa, Ethiopia. 1989.

5. 5th World Congress on Gestational Trophoblastic Diseases. London. 3-5 October 1990.

6. 8th Congress of Confederation of African Medical Associations and Societies (CAMAS). The Health of the African Mother and Child. Accra, Ghana. 2-7 December 1990.

7. 1st All Nigeria Conference on AIDS Nigerian Medical Association Otta, Nigeria. 31 March - 1st April, 1990.

8. Consultative Group Meeting on How to Eliminate Unsafe Abortion in Nigeria. Nigerian Medical Association 16 - 17 August 1991. Ota, Nigeria.

9. XIII World Congress on Gynaecology and Obstetrics (FIGO), Singapore. 13 - 19 September, 1991.

10. 9th Congress of Confederation of African Medical Associations and Societies (CAMAS) on Policy Issues in Management of AIDS/HIV Infection. Blantyre, Malawi. 8 - 12 March, 1992.

11. 2nd All Nigeria Conference on AIDS, Nigerian Medical Association Ota, Nigeria. 31st March - 1st April, 1992.

12. International Symposium and Training Workshop on Reproductive Health in Developing Countries of the Commonwealth. Kingston, Jamaica. 30 October - 3rd November, 1992.

13. 3rd All Nigeria Conference on AIDS, Nigerian Medical Association Ota, Nigeria. 28 - 30 March, 1993.

14. International Symposium on Reproductive Health in Developing Countries. South to South Cooperation on Reproductive Health in Developing Countries, Lagos, Nigeria. 9 - 15 May, 1993.

15. Book Production Workshop, West Africa Postgraduate Medical College (WAHC), Ibadan. 18 - 21 August 1993.

16. 9^TH Congress of the Confederation of Africa Medical Associations and Societies (CAMAS). Blantyre, Malawi. 1993.

17. Round Table Conference on the Effect of structural Adjustment Programme (SAP) on Health and Social Services in Africa. Maseru, Lesotho. 12-16 September 1993.

18. 10th Congress of the Confederation of African Medical Associations and Societies (CAMAS) on Improving Health in Africa. Strategies for Action, Abidjan, Cote d'Ivoire. 12 - 17 September 1994.

19. XIV World Congress of Gynaecology and Obstetrics (FIGO) 1994. Montreal, Canada; 23 - 30 September, 1994.

20. Surgical Techniques in Gynaecological Malignancies. European School of Oncology Course, Budapest. Hungary, 25-26 November, 1994.

21. Obstetrics, Gynaecology, Perinatal Medicine and the Law - Twelfth Annual Conference, Wailea, Maul, Hawaii 2 - 6 January, 1996.

22. Abortion Matters: International Conference on reducing the need for abortion. Amsterdam, Netherlands 27-29 March 1996.

23. 9th World Congress of Cervical Pathology & Colposcopy. Sydney, Australia, May 12 - 16, 1996.

24. Royal Postgraduate Medical School Courses: Medical problems Facing Obstetricians and Physicians in Pregnancy. London 2 - 4 October, 1996.

25. 30th Annual General Meeting and Scientific Conference of the Society of Gynaecology and Obstetrics of Nigeria (SOGON), University of Ibadan. 27 - 30 November, 1996.

26. 3rd EUROGIN International Congress on Lower Genital Tract Infections and Neoplasia UNESCO, Paris 24 - 27 March, 1997.

27. 3rd Afro- Implement Workshop. Nyanga, Zimbabwe 2 - 6 April, 1997.

28. Magpie Trial: Use of Magnesium Sulphate for Prevention of Eclampsia: Collaborators Meeting, Liverpool, 13 - 16 April, 1997.

29. XVth FIGO World Congress of Gynaecology and Obstetrics. Copenhagen, Denmark 2 - 8 August 1997.

30. 12th Congress of the Confederation of African Medical Associations and Societies (CAMSA) on Quality Assurance in Health Care Delivery in Africa, Maseru, Lesotho, 25 - 29 August, 1997.

31. The Magpie Trial Collaborators Meeting. St. Catherine's College Oxford 25 - 26 September 1998.

32. International Network for Control of Gynaecologic Cancers (INGGC) Consensus Conference on Cervical Cancer Screening and Management. Tunis, Tunisia. 28 - 31 January 1999.

33. 5^th International Congress of the Society of Gynaecology and Obstetrics of Nigeria. Benin-City, Nigeria. 25-28, 1998.

34. International Network for Control of Gynaecologic Cancers (INCGC).African Regional Technical/Training Workshop on Cervical Cancer. Ibadan, Nigeria. 10-15 April, 2000.

35. X111International AIDS Conference. Durban, Republic of South Africa. 9-13July, 2000.

36. National Conference on Reducing Morbidity & Mortality from unsafe Abortion. Abuja, Nigeria. 24-28 July, 2000.

37. XVI International Federation of Gynaecology and Obstetrics (FIGO) World Congress, Washington. USA. 3-8 September, 2000.

38. Ethical Issues in Health Research- Workshop organised by the AIDS Prevention Initiative Nigeria(APIN), Program on Ethical Issues in Reproductive Health at the Harvard School of Public Health. Abuja, Nigeria. December 3-7, 2001.

39. Building Strategic Partnership in Education and Health in Africa. Consultative meeting on improving collaboration between Health Professionals, Governments and other stakeholders in Human Resources for Development. Addis Ababa, Ethiopia. 29 February-1 February 2002.

40. Workshop on Data Management in Public Health Projects. Harvard School of Public Health, Boston, USA. 12-16 August, 2002.

41. Joint Workshop on APIN Phase 2 –Policy and Institutional capacity Module. Harvard School of Public Health, Boston, USA. 28-30 October, 2002.

42. International Conference of the Society of Gynaecology and Obstetrics Of Nigeria (SOGON). Abuja, Nigeria.

43. HIV Vaccines for Developing Countries. The Tenth Think Tank Symposium of the Harvard AIDS Institute series on Vaccine Solutions for Developing Countries. Abuja, Nigeria. 18-21 February, 2003.

44. Workshop on National HIV/AIDS Accounts. NISER-UI-APIN-HSPH Joint Project. NISER, Ibadan. 22-23 July, 2003.

45. Ethical Issues in International Health Research. Joint University of Ibadan, Harvard School of Public Health and AIDS Prevention Initiative, Nigeria (APIN) Workshop. International Institute of Tropical Agriculture, Ibadan. 27 August- 2 September, 2003.

46. 14^th International Conference on STD’s and AIDS in Africa. Nairobi, Kenya, 22-27 September 2003.

47. XV11 FIGO World Congress, Santiago, Chile 2-7, November, 2003.

48. National Reproductive Health Summit, Abuja, Nigeria. April, 2004.

49. 4^th National Conference on HIV/AIDS in Nigeria, Abuja, Nigeria 2-5 May 2004.

50. Fourth Strategy Meeting of The International HapMap Project. Melville, NY 11-12 May, 2004.

51. National Bioethics Workshop, Conference Centre, University of Ibadan.

52. XV International AIDS Conference, Bangkok, Thailand. 11-16 July,2004.

53. 34^th National Conference of the Society of Gynaecology and Obstetrics of Nigeria. Markurdi.17-19 November, 2004.

54. Fifth Strategy Meeting of the International Hap Map Project, Cambridge, UK.

55. Tenofovir Consultation Meeting, Atlanta, Georgia, 9-10 December, 2004.

56. 4^th International Cervical Cancer Conference, Houston Texas,18-22 May 2005.

57. Prevention of Mother to Child Transmission (PMTCT) of HIV and Pediatric HIV Care, Abuja Nigeria 1-4 June, 2005.

58. 3^rd International Conference on Pathogenesis and Treatment, Rio de Janeiro, 24-27 July,2005.

59. 39^th Annual general meeting and Scientific Meeting of Society of Gynaecology and Obstetrics of Nigeria. Health Sector Reform. Ibadan, Nigeria. 22-25 November, 2007.

60. 1st African HPV Expert Panel, Johannesburg, South Africa, 15^th December 2005.

61. Linking Research To Action to Reduce Unsafe Abortion in Sub-Sahara Africa: A Regional Consultation” United Nations Conference Center in Addis Ababa, Ethiopia, 19-23 March 2006.

62. European Research Organization for Genital Infection and Neoplasia.Palais des Congrès Paris, France 24-27 April, 2006.

63. High Level Inter-Ministerial Meeting on Health Research for Disease Prevention and Development. La Palm Beach Hotel Accra, Ghana 15-17 June, 2006.

64. 2^nd African HPV meeting, Cape Town, South Africa. 3^rd August, 2006.

65. 16^th International AIDS Conference, International Convention Center, Toronto, Canada 13-18 August, 2006.

66. XV111 FIGO World Congress of Gynecology and Obstetrics, International Convention Center , Kuala Lumpur. 5-10 November, 2006.

67. 2^nd Tri-Country PEPFAR Conference, Dar es Salaam, Tanzania 15-18 November,2006.

68. 7^th International Scientific Conference and 40^th Annual General Meeting of Society of Gynaecology and Obstetrics of Nigeria. Improving maternal health-MDG 5.Abuja Nigeria. 21-25 November, 2006.

69. Curriculum Review Meeting on Integration of Sexual and Reproductive health and Rights into Nigerian Medical School. Gateway Hotel, Ota, Nigeria. 14-17 December, 2006.

70. 3^rd SSA HPV Meeting ,Cape Town, South Africa.22 January, 2007

71. 1st Global Health Design Challenge Symposium: Integrated Technology Solutions to Advance Global Health. The James Baker 111 Institute for Public Policy, Rice University,Houston,Texas.17-18 April, 2007.

72. HPV Vaccines Trial-IDMC Meeting, Brussels, Belgium- 13 July, 2007.

73. 1^ST Operation Stop Cervical Cancer in Africa. Accelerating Access to HPV Vaccines. Sheraton Hotel and Towers, Abuja. 24-25 July, 2007.

74. 16^th Engineering Assembly: Theme- Millennium Development Goals: Prospects and Challenges to the Engineering Profession in Nigeria. International Conference Abuja, 28-29 August, 2007.

75. 37^th Interdisciplinary Research Discourse. Postgraduate School, University of Ibadan. Reproductive Health and Sustainable Development-The Missing MDG.

76. 6^th International AORTIC Conference. Cancer in Africa. Challenges and Opportunities. Cape Town, South Africa.24-28 October, 2007.

77. HPV Masterclass-Sandton Hilton, Johannesburg, South Africa.26-27 February, 2008.

78. 3^rd International Conference on HIV Treatment Adherence, Jersey City, New Jersey-17-18 March, 2008.

79. 5^th Cervical Cancer Working Group-Expert Panel,Lagos,Nigeria-7^th May, 2008.

80. PMTCT/Ped HIV Conference-APIN Plus, Harvard Pepfar- Abuja,Nigeria-19-21 May,2008.

81. 2^nd Stop cervical cancer in Africa Conference. Kampala Uganda-21 22 July,2008-07-26.

82. SOCRON Conference on Modern Management of Cancer, Ibadan, Nigeria-22-24 July, 2008.

83. Cancer Consultative Meeting. Federal Ministry of Health, Abuja - 21-22 August, 2008.

84. 20^th World Cancer Congress, Geneva Switzerland. 27-31 August, 2008.

85. Harvard Pepfar Tri-Country Meeting. Gabarone Botswana.8-12 September, 2008.

86. WHO regional Consultative Meeting on Cervical Cancer Prevention and Control. Quagadougou, Burkina Faso.16-17 September, 2008.

87. 42^nd Annual Scientific Conference in Obstetrics and Gynaecology: Society of Gynaecology and Obstetrics of Nigeria. 14-17 November, 2008.

88. 15^th International Conference of AIDS and STI in Africa. Dakar Senegal. 3-7 December, 2008.

89. 6^th Sub-Saharan African Cervical Cancer Working Group. Nairobi, Kenya. 09 December, 2008.

90. Sexual practice among people living with HIV at the University College Hospital, Ibadan, Nigeria. 15th International Conference of AIDS and STI in Africa. Dakar, Senegal. 3-7 December, 2008.

91. 7th Sub-Saharan African Cervical Cancer Working Group. Accra Ghana. 26^th May, 2008.

92. APIN Plus-PMTCT/Pediatric Care Conference, Abuja, Nigeria. 16^th June, 2009.

93. 3^rd Stop cervical cancer Conference in Africa. Cape Town, South Africa 19-21 July, 2009.

94. 5^th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention Retroviruses Cape Town, South Africa 19-22 July, 2009.

95. International Conference of Medical Women’s Association of Nigeria. Abuja, Nigeria. 24th September, 2009.

96. XIX FIGO World Congress, Cape Town, South Africa 4-9 October, 2009.

97. 8th Sub-Saharan African Cervical Cancer Working Group. Dar-es-Salaam,Tanzania,9^th November, 2008.

98. 2009 AORTIC Congress, Dar Es Salaam, Tanzania 11-14 November, 2009.

99. Society of Obstetric and Gynaecology of Nigeria (SOGON) 2009 Conference, Kano, Nigeria 19-21 November, 2009.

100. UICC Capacity Building Workshop on Cancer Prevention-Cape Town, South Africa 22-24 March, 2010.

101. 5^th National AIDS Conference, Abuja, Nigeria. 2 – 5 May, 2010.

102. 9th sub Saharan Africa Cervical Cancer Working Group, Lusaka,Zambia.17th May,2010

103. Experts in Cervical Cancer Education and Leadership (EXCCEL).Anglophone West Africa Expert Speakers’ Forum,Lagos, Nigeria,16 September 2010

104. An international workshop on the estimation of health system and individual costs of abortion and post abortion services. Addis Ababa, Ethiopia. 27-29 September, 2010.

105. Orientation Training for staff from institutions and consultants for IPTS for Sexual and Reproductive Health & Rights. Johannesburg, South Africa 4-9 October, 2010.

106. 10^th sub Saharan Africa Cervical Cancer Working Group, garborone,Bostwana.23-24 November,2010.

107. Expert Assignment: WHO-IAEA 2nd WHO/IAEA Supported Coordination Meeting RAF/6/041 – Supporting Comprehensive National Cancer Control Dakar, Senegal 24-26 November 2010 ( C3-RAF/6/041 9005 01 )

108. AORTIC strategic Planning Meeting. Dakar ,Senegal 29^th November,2010

109. Going Global Educational Conference, HongKong,10-12 March,2011

110. Global Health Conference, Northwestern University, Chicago, Illinois, 2-6 April, 2011

111. ASCO 2011 Annual Meeting, Chicago,I llinois,USA,3-7 June,2011

112. 11^th sub Saharan Africa Cervical Cancer Working Group, Johannesburg, South Africa.05 September,2011

113. Centers of Excellence Summit, Kampala, Uganda.12-13 September,2011

114. AORTIC 2011 Congress, Cairo, Egypt, 29 November- 02 December,2011

115. 4^th Annual Summit of Global Network of Masters of Development Practice Program.Dhaka,Bangladesh.6-10 February,2012

116. Expert in Cervical Cancer Education and Leadership (EXCCEL) Workshop- Francophone. Abidjan, Cote D’Ivoire.22 February,2012

117. 12^th sub Saharan Africa Cervical Cancer Working Group, Kampala, Uganda.23-24 April,2012.

118. Expert in Cervical Cancer Education and Leadership (EXCCEL) Workshop- Anglophone. Accra, Ghana.24 May,2012

119. Expert Mission: IAEA -VCCUnet Annual Stakeholders Meeting, Lusaka Zambia.9-11 July,2012 ( C3-RAF/6/043 9003 01)

120. 2012 Annual MEPI Symposium-Building Partnership and Enhancing Sustainability. Addis Ababa, Ethiopia. 7-9 August, 2012

121. UICC 2012 World Cancer Congress. Montreal, Canada. 27-30^th August, 2012

122. 13^th sub Saharan Africa Cervical Cancer Working Group, Dakar, Senegal. 21-22 September,2012.

123. FIGO World Congress of Gynecology and Obstetrics, Rome,Italy 7-12 October,2012

124. Expert Mission, Member of Gavi Independent Review Committee, Gavi Alliance, Geneva, Switzerland, 4-19,October,2012

125. Expert Mission, Member of Gavi Independent Review Committee, Gavi Alliance, Geneva, Switzerland. 19-23,November,2012

126. Co-Chair- Exccel Dubal, Dubai, UAE, 05-06 May,2013

127. Inaugural meeting of Australia Africa Universities Network (AAUN),Sydney, Australia.7-11 July,2013

128. 14^th sSSA CCWG, Johannesburg, South Africa.14-15 July,2013

129. Expert Assignment: Co Chair 4^th VUCCnet Annual Stakeholders Meeting, Vienna,Austria. 23-25 July,2013 ( C3-RAF/6/043-9007 01)

130. First African Regional Congress of the International Federation of Gynecology and Obstetrics (FIGO). Addis Ababa, Ethiopia, 2-5 October,2013

131. African Organisation for Research and Training in Cancer (AORTIC) 9^th International Cancer Conference: Cancer in Africa, Bridging Science and Humanity. Durban, South Africa, 21-24 November,2013

Communications at Scientific Conferences

1. Osinusi B, Adewole IF, & Laditan, A.O. Management in Intersexual Disorders. 16th National Conference of the Society of Gynaecology and Obstetrics of Nigeria (SOGON) Ibadan, Nigeria. 8 - 10th November, 1984.

2. Adewole IF. Changing Parameters of Gestational Trophoblastic Diseases in Nigeria,5th World Congress on Gestational Trophoblastic Diseases, London. 23 - 25th October, 1990.

3. Adewole, IF. Trends in Post Abortal Mortality and Morbidity in Nigeria. 8th Congress of Confederation of African Medical Associations and Societies (CAMAS) on the Health of the African Mother and Child. Accra. 2 - 7 December 1990.

4. Adewole, IF. Problems of Unsafe Abortion in Nigeria - An Overview. Consultative Group Meeting on How to Eliminate Unsafe Abortion in Nigeria. Ota, Nigeria. 16 - 17 August, 1991.

5. Adewole IF. The concept of Networking in Advocacy Campaign - An Overview. Consultative Group on Networking to Eliminate Unsafe Abortion in Nigeria. Campaign Against Unwanted Pregnancy (CAUP). Ota, Nigeria. 2 - 5 June 1994.

6. Adewole IF. That Our Women May Live. International Conference in Reproductive Health Initiatives on Private Medical Practice: Association of General and Private Medical Practitioners of Nigeria (AGPMPN), Lagos. Nigeria. 18th March, 1994.

7. Adewole IF,Babarinsa IA, Ayinde A. Influence of Time and Marital Pattern in the Development of CIN. 9th World Congress of Cervical Pathology and Colposcopy. Sydney. Australia. 12 - 16 May, 1996.

8. Adewole IF, Fawole AO, Babarinsa IA. The value of antenatal screening for Syphilis at the University College Hospital, Ibadan. 30th Annual Scientific Conference of Society of Gynaecology and Obstetrics of Nigeria (SOGON) 27 - 30th November, 1996, Ibadan Nigeria.

9. Adewole IF, Babarinsa IA, Atere WA, Aderinto Y, Bakare, RA. and Oni, A.A. Sexual behaviour of husbands of pregnant and recently delivered women in Ibadan - inferences from a focus group study. 30th Annual Scientific Conference of society of Gynaecology and Obstetrics of Nigeria (SOGON) 27 - 30th November, 1996, Ibadan. Nigeria.

10. Oladimeji, AO, Ayuba TT, Adewole IF, Babarinsa IA, Bakare, RA., and Oni, AA. Clinico-Pathologic study of vaginal discharge in Ibadan. 30th Annual Scientific Conference of Society of Gynaecology and Obstetrics of Nigeria (SOGON) 27 - 30th November, 1996. Ibadan, Nigeria.

11. Adewole IF.Odeniyi GD, Fashina, NA, Ogunbiyi JO. The relative value of bacteriology and Cytology in the diagnosis of sexually transmissible diseases. 30th Annual Scientific Conference of Society of Gynaecology and Obstetrics of Nigeria (SOGON) 27 - 30 November 1996, Ibadan, Nigeria.

12. Bakare, RA, Oni, AA, Shokunbi, WO, Ogundiran, N., Ayuba TT., Babarinsa, IA. Odeniyi, GD., Fawole, AO., Adewole IF. Spectrum of detectable microbes amongst commercial sex workers in Ibadan. 30th Annual Scientific Conference of Society of Gynaecology and Obstetrics of Nigeria (SOGON) 27 - 30 November, 1996. Ibadan, Nigeria.

13. Adewole IF,Fawole, AO, Fashina, NA., Ayuba, TT., Bakare, RA. and Babarinsa IA. Medical audit of private medical laboratory services in the management of STD's. 30th Annual Scientific Conference of society of Gynaecology and Obstetrics of Nigeria (SOGON) 27 - 30 November 1996, Ibadan, Nigeria.

14. Fashina, NA, Adewole IF, Oni A.A, Odeniyi, GD., Fawole AO. and Bakare R.A. Giemsa stain as a rapid screening test in the diagnosis of STD's. 30th Annual Scientific Conference of Society of Gynaecology and Obstetrics of Nigeria (SOGON) 27 - 30th November, 1996, Ibadan, Nigeria.

15. Adewole IF, Fawole AO., and Babarinsa IA. Cervical Cancer Screening in Nigeria. 3rd EUROGIN International Congress on Lower Genital Tract Infection and Neoplasia. UNESCO, Paris. 24 - 27 March, 1997.

16. Adewole IF, Fawole AO., and Babarinsa IA. Trends in Cervical Cancer in Young Nigerians over a 16 year period. XVth FIGO World Congress of Gynaecology and Obstetrics Copenhagen, Denmark. 2 - 8 August, 1997.

17. AdewoleIF. Quality Assurance in Reproductive Health. XII Congress of Confederation of African Medical Associations and Societies (CAMAS) Maseru, Lesotho 25 - 29 August, 1997.

18. Adewole IF, Oladokun A, Okewole AI, Omigbodun AO, AfolabiKA, Ekele B, Audu LR, Obed Y. Magnesium Sulphate for the treatment of eclampsia: The Nigerian Experience. 5^th International Congress of the Society of Gynaecology and Obstetrics of Nigeria.25-29 November 1998.

19. Adewole IF, Oye-Adeniran BA, Iwere N, Mohammed P, Olawuyi F, Ekanem EE, Babarinsa IA, Gbadegesin A, Ogedegbe OK, Oloruntimehin OO, Omigbodun AO & Emuveyan EE. 5^th International Congress of the Society of Gynaecology and Obstetrics of Nigeria. 25-29 November 1998.

20. Adewole IF, Awe SO, Makinde M, Fawole AO, Bello BS, Marinho AO, Adeyi YO, Olawuyi O, Fakolujo A & Kotila RT. Contraceptive and anti-fertility effects of ricinus communis.5^th International Congress of the Society of Gynaecology and Obstetrics of Nigeria. 25-29 November, 1998.

21. Oladokun A, Babarinsa IA, Adewole IF, Omigbodun AO & Ojengbede OA. Impact of sitz baths and prophylactics on episiotomy wound healing. 5^th International Congress of the Society of Gynaecology and Obstetrics of Nigeria. 25-29 November, 1998.

22. Oladokun A, Babarinsa IA, Adewole IF & Omigbodun AO.A comparative study of McDonald and Shirodkar methods of cerclage in management of cervical incompetence in University College Hospital, Ibadan. 5th International Congress of the Society of Gynaecology and Obstetrics of Nigeria. 25-29 November, 1998.

23. Odukogbe AA, Adewole IF, Ojengbede OA, Olayemi O, Fawole A, Ahmed A. Advanced Parity: Pregnancy after the fifth delivery. A study of two hospital settings. 32^nd congress of the Society of Gynaecology and Obstetrics of Nigeria. Lagos, Nigeria. 24-27 November, 1999.

24. Adewole IF. Maternal Mortality Versus Cervical Cancer .A call for Action. African Regional Technical/Training Workshop on Cervical Cancer. International Network for Control of Gynaecologcal Cancers (INCGC).Ibadan, Nigeria. 10-15 April, 2000.

25. Adewole IF. Defect in the Abortion Law. National Conference on Reducing Morbidity and Mortality in Nigeria. Abuja, Nigeria.24-28 July, 2000.

26. Oladokun A., Babarinsa IA., Adewole IF. The Impact of Health Education in the Promotion of Cervical Cancer Screening in Developing Countries. International Journal of Gynecology & Obstetrics (Book of Abstracts). 2000. Vol. 70; supplement No. 1. Pp. 100 – 101.

27. Babarinsa IA, Adewole IF, Oladokun A. Myometrial Resections: Preliminary Report of a Uterine – Conserving Procedure for Myohyperplasia. International Journal of Gynecology & Obstetrics (Book of Abstracts). 2000. Vol. 70; supplement No. 1. Pp. 27.

28. Babarinsa IA, Oladokun A, Adeyemo I, Adewole IF. Should the Partogram be adapted for term vaginal breech deliveries? nternational Journal of Gynecology & Obstetrics (Book of Abstracts). 2000. Vol. 70; supplement No. 1. Pp. 62.

29. Adewole IF. Prevention of Mother to Child Transmission of HIV. International Conference of the Society of Gynaecology and Obstetrics of Nigeria. Abuja, Nigeria. November 2002.

30. Adewole IF. Ethical Issues in Reproductive Health. Workshop on Ethical Issues in Health Research. IITA, Ibadan, Nigeria. 27 August-2 September, 2003.

31. Adewole IF, Adesina OA, Olaleye D, Odaibo G, Kanki P, Sankale JL. HIV Western Blot Indeterminate Results in a PMTCT Program. 4^th National Conference on HIV/AIDS in Nigeria. Book of Abstracts A218.

32. Adewole IF. ART Therapies in PMTCT. Satellite Session on PMTCT. 4^th National Conference on HIV/AIDS in Nigeria. 3^rd May 2004.

33. Adewole IF. The challenges of conducting ethically sound research in a developing country. Key-note Presentation at the Bioethics workshop. University of Ibadan, Ibadan.

34. Adewole I, Jegede A, Adesina A, Bamgboye A, Adejumo P, Smart P, Adegbola M, Sankale P, Kanki P. Male responsibilities in the prevention of mother to child transmission of HIV in Nigeria. XV International AIDS Conference, Bangkok, Thailand. 11-16 July, 2004.

35. Adewole I, Osowole O, Aborkor L, Adesina A, Sankale P, Kanki P. pinion Leaders Awareness and Perception of Mother to Child Prevention of Mother to Child Transmission of HIV in Nigeria. XV International AIDS Conference, Bangkok, Thailand. 11-16 July, 2004.

36. Adewole IF.PMTCT Safeguarding the future. Symposium of the Society of Gynaecology and Obstetrics of Nigeria ( SOGON) Symposium. Ibadan, 22^nd October,2004.

37. Adewole IF, ARV in Prevention of Mother to child Transmission of HIV. 34^th National Conference of the Society of Gynaecology and Obstetrics of Nigeria. (SOGON). Makurdi, Nigeria. 17-20, November,2004.

38. Adewole IF, The benefits and Risks of Breastfeeding- Prevention of Mother to Child Transmission (PMTCT) of HIV and Pediatric HIV Conference, Abuja Nigeria. 1-4 June,2005

39. Henshaw SK, Adewole IF, Singh S, Bankole A, Oye-Adeniran BA, Hussain R, Sedgh G. Characteristics of women seeking abortion services and post-abortion care in Nigerian hospitals. Presented at the International Union for the Scientific Study of Population, General Conference, July 2005, Tours, France.

40. Adewole IF. Reaching Women with Safe Abortion in their Communities: Research Perspectives: Linking Research to Action to Reduce Unsafe Abortion in Sub-Saharan Africa: A Regional Consultation” United Nations Conference Center in Addis Ababa, Ethiopia, 19-23 March 2006.

41. Adewole IF. Burden of Cervical Cancer in West Africa.1^st HPV Expert panel meeting. Johannesburg, South Africa . 15^th December, 2005.

42. Adewole IF. Challenges of Cervical Cancer Screening in Africa. The Nigerian Experience. 3^rd SSA HPV Meeting Cape Town, South Africa. 25 January, 2007.

43. Adewole IF. Achieving the Health Millennium Development Goals in the Developing World: The Expected Innovative Biotechnology Solutions. The 1^st Annual Global Challenge Design Symposium. Houston, Texas, USA. 17-18 April, 2007.

44. Adewole IF. Cervical Cancer in Africa. Keynote Address.1^st Stop Cervical Cancer in Africa. Accelerating Access to HPV vaccines. Abuja, Nigeria 24-25 July, 2007.

45. Adewole IF. Engineering Requirement for Reduction of Child Mortality, Enhancement of Maternal Health and Eradication of HIV/AIDS and Malaria.16^th Engineering Assembly, Abuja, Nigeria. 28-29 August, 2007.

46. Adewole IF. Undergraduate Medical Education: Yesterday, Today and Tomorrow.5^th Biennial Scientific Conference and Delegates Meeting. Abuja, Nigeria 5-9 September, 2007.

47. Adewole IF. Cervical Cancer in Africa. Why is it so common. 6^th International AORTIC Conference. Cancer in Africa. Challenges and Opportunities. Cape-Town, South Africa. 24-28 October, 2007.

48. Adewole IF. Cervical Cancer Facts-Advocacy Workshop for Journalists-Sheraton Hotel, Lagos, Nigeria 5^th May, 2008.

49. Adewole IF. Cervical Cancer Vaccines Update-Advocacy Workshop for Journalists-Sheraton Hotel, Lagos -5^th May, 2008-06.

50. Adewole IF. Review of APIN Plus PMTCT Protocol. Harvard Pepfar PMTCT/Ped HIV Conference. Abuja, Nigeria.19-21 May, 2008.

51. Adewole IF. Care of HIV Positive Women. Harvard Pepfar PMTCT/Ped HIV Conference. Abuja, Nigeria. 19-21 May, 2008.

52. Adewole IF. Guidelines for HPV vaccine Use in sub-Saharan Africa-2^nd Stop cervical Conference in Africa. Kampala Uganda-21 July, 2008.

53. Adewole IF. Recent Advances in the Epidemiology and management of Advanced Cervical Cancer. Ist SOCRON Conference on the Modern management of Cancer. Ibadan, Nigeria. 24 July, 2008.

54. Adewole IF. Operation Stop Cervical Cancer in Nigeria. Cancer Consultative Meeting. Federal Ministry of Health, Abuja-21-22 August, 2008.

55. Adewole IF. PMTCT and Infant Feeding in Nigeria. Harvard Pepfar Tri-Country Meeting. Gaborone, Botswana. 8-11 September, 2008.

56. Adewole I F. Updates on HPV Infection and Epidemiology. WHO regional Consultative Meeting on Cervical Cancer Prevention and Control. Quagadougou, Burkina Faso.16-17 September, 2008.

57. Adewole IF. Female genital cancers and Reproductive Health care in Nigeria. Pre Conference Workshop on Reproductive health in developing Countries.42^nd Annual Scientific Conference of the Society of Gynaecology and Obstetrics of Nigeria. Enugu, Nigeria. 18-22 November, 2008.

58. Adewole IF. Vaccines for Prevention of Cervical Cancer. Pre-Conference Workshop on Cervical Cancer Prevention in Low Resource Settings. 42^nd Annual Scientific Conference of the Society of Gynaecology and Obstetrics of Nigeria. Enugu, Nigeria. 18-22 November, 2008.

59. Adewole IF. Cervical Cancer Facts. GSK Presentation on Vaccines for Prevention of Cervical Cancer. 42^nd Annual Scientific Conference of the Society of Gynaecology and Obstetrics of Nigeria. Enugu, Nigeria. 18-22 November, 2008.

60. Adesina O, Akinyemi O, Oladokun A, Awolude O, Roberts A, Odaibo G, Olaleye OD, Adewole IF, kanki P. Hepatitis B and C co-infection in HIV pregnant Women in PMTCT Programme. 42^nd Annual Scientific Conference of the Society of Gynaecology and Obstetrics of Nigeria. Enugu, Nigeria. 18-22 November, 2008.

61. Awolude O, Akinyemi O, Adesina OA, Adewole IF. PMTCT programme Uptake among HIV positive Pregnant Women. 42^nd Annual Scientific Conference of the Society of Gynaecology and Obstetrics of Nigeria. Enugu, Nigeria. 18-22 November, 2008.

62. Odukogbe AA, Akinwuntan AL, Adewole IF. Gestational Trophoblatic Diseases –Contemporary Issues. 42^nd Annual Scientific Conference of the Society of Gynaecology and Obstetrics of Nigeria. Enugu, Nigeria. 18-22 November, 2008.

63. Oladokun A, Morhason-Bello IO, Adewole IF, Miller D, Follen M. The Learning Curve of Radical Hysterectomy for early stage Cervical Carcinoma: Lessons from Operation Stop Cervical Cancer Project. 42^nd Annual Scientific Conference of the Society of Gynaecology and Obstetrics of Nigeria. Enugu, Nigeria. 18-22 November, 2008.

64. Adewole IF, Sagay AS .Operational Research on PMTCT in the APIN Plus/Harvard PEPFAR Program. Satellite Symposium, 15^th International Conference of AIDS and STI in Africa. Dakar, Senegal. 3-7 December, 2008.

65. Adewole IF. Sexual practice among people living with HIV at the University College Hospital, Ibadan, Nigeria. 15th International Conference of AIDS and STI in Africa. Dakar, Senegal. 3-7 December, 2008.

66. Adewole IF. Review of APIN Plus PMTCT Protocol. APIN Plus -PMTCT/Pediatric Care Conference, Abuja, Nigeria. 16^th June, 2009.

67. Adewole IF. The Reproductive health needs of HIV Positive women. APIN Plus -PMTCT/Pediatric Care Conference, Abuja, Nigeria. 17^th June, 2009.

68. Adewole IF. Networking to Prevent Cervical Cancer: The African Experience .3^rd Stop cervical cancer Conference in Africa. Cape Town, South Africa 19-21 July, 2009.

69. Adewole IF. Cancer Screening in HIV Positive Women: The African Experience .3^rd Stop cervical cancer Conference in Africa. Cape Town, South Africa 19-21 July, 2009.

70. Adewole IF. After Cervical Cancer Screening: What next? International Conference of Medical Women’s Association of Nigeria, Abuja, Nigeria. 24th September, 2009.

71. Adewole IF. Perspectives on Cervical Cancer in Developing Countries: What the Future Holds for Africa. XIX FIGO World Congress, Cape Town, South Africa 4-9 October, 2009.

72. Adewole IF. HPV in the HIV Infected Woman. XIX FIGO World Congress, Cape Town, South Africa 4-9 October, 2009.

73. Adewole IF. What is the real burden of cervical Cancer in Africa.2009 AORTIC Congress, Dar Es Salaam, Tanzania, 11-14 November, 2009.

74. Adewole IF. Cervical Cancer Prevention in Nigeria: Where are we? Society of Obstetrics and Gynaecology of Nigeria 2009 Annual Conference. Kano, Nigeria 19-21 November, 2009.

75. Adewole IF.Immunology and efficacy of HPV vaccines. Experts in cervical cancer Education and Leadership (EXCCEL).Anglophone West Africa Expert Speakers’ Forum,Lagos, Nigeria,16 September 2010.

76. Adewole IF. Status and needs for cancer control in Sub-Saharan Africa. WHO-IAEA 2nd WHO/IAEA Supported Coordination Meeting RAF/6/041 – Supporting Comprehensive National Cancer Control Dakar, Senegal 24-26 November 2010

77. Adewole IF, Prevention of Mother to Child Transmission of HIV.Global Health Conference, Northwestern University, Chicago, Illinois,2-6 April,2011.

78. Adewole IF. Life and Earth Sciences Institute, Pan African University.Centers of Excellence Summit, Kampala, Uganda.12-13 September,2011

79. Adewole IF. Working together to Change the Trajectory of Cancer in Africa.AORTIC 2011 Congress, Cairo, Egypt, 01 December,2011

80. Adewole IF. Africa and Cancer: Preparing for the next Epidemic. Quarterly Guest Lecture of the Nigerian Academy of Science, Lagos, Nigeria. 27^th January,2012

81. Adewole IF.The role of screening and effective vaccination programmes in cervical cancer prevention.Expert in Cervical Cancer Education and Leadership (EXCCEL) Francophone Workshop. Abidjan, Cote d’Ivoire.13^th February,2012

82. Adewole IF. Opening Remarks.Setting Priorities for Global Cancer Research, NCI Bethesda,Maryland,USA.13-14 March,2012

83. Adewole IF. GAVI Criteria for HPV Vaccine Implementation. 12^th sub Sahara Africa Cervical Cancer Working Group (sSA CCWG). Kampala,Uganda.24^th April,2012

84. Adewole IF;GAVI procedures for HPV vaccination support; Expert in Cervical Cancer Education and Leadership (EXCCEL) Anglophone Workshop. Accra, Ghana.24^th May,2012

85. Adewole IF. Opening Address to the IWAEA VUCCnet Stakeholders Meeting.Lusaka,Zambia.09 July,2012

86. Adewole IF. Perspectives from the Field: Challenges and Opportunities in Education and Training in Low and Middle-Income Countries. UICC 2012 World Cancer Congress. Montreal, Canada. 29^th August,2012.

87. Adewole IF. The place of pathology in Oncologic practice from the perspective of a clinical oncologist. AORTIC-Africa Pathology Summit, Dakar ,Senegal.22 march,2013.

88. Adewole IF. Opportunities and Needs for Cancer in Africa. AORTIC Cancer Leadership Institute, AORTIC 9^th International Cancer Conference, Durban, South Africa. 22 November, 2013

89. Adewole IF.What does the Gynaecologic Oncologist Need from the Pathologist.AORTIC 9^th International Cancer Conference, Durban, South Africa. 24 November, 2013

Researches

Search Activities

Evaluating novel ideas for promoting Cervical Cancer Screening in developing countries.

Multi Country study on HPV in Cervical cancer among African Women

Nation-wide study to determinants of unsafe abortion in Nigeria.

Pilot Study of Maternal Mortality in Nigeria

Community based Study on Emergency Contraception in Nigeria

Attitude of HIV +ve pregnant women to contraception and couple counselling.

Study of the Efficacy of Maternal Antiretroviral Intervention and Infant Antiretroviral prophylaxis for the prevention of Mother –to-Child transmission of HIV in Nigeria

Advocacy

Co-ordinator - Campaign Against Unwanted Pregnancy, a multidisciplinary non-profit initiative comprising of doctors, lawyers, media practitioners, social scientists, teachers and Nurses.

Involved with Advocacy work designed to reduce the burden of Unsafe Abortion in Nigeria.

Leading Advocacy to promote nationwide access to cervical cancer screening

Integration of Sexual and Reproductive Health and Rights in the Curriculum of Medical Schools in Nigeria/Africa

Activities undertaken

Abortion Law Review Meeting

Public Symposia/Meetings on Abortion

Media sensitisation campaign

Workshops for Opinion and Community leaders

Working with Young persons in the Medical Schools of Nigerian Universities.

Research on the size of the Abortion problem in Nigeria

Review of Reproductive Health content of Medical Curriculum.

Project Director –PMTCT Project –UI/UCH.

Member National PMTCT Task Force

Funding Support (Active)

1. 1D43 TW007995– 01/06/08 - 31/5/11 $55,278

Northwestern University AIDS International Training and Research Program( AITRP

As Institutional Country Liaison Officer, I manage the training program at the University College Hospital, Ibadan, Nigeria.

The program provides training support for Academic staff of College of Medicine, University of Ibadan

2. U51HA025522-04 – 01/03/2012 - 28/2/2013 $1,977,532.00

President's Emergency Plan for AIDS Relief – HRSA

Accelerated HIV and AIDS Treatment Program

I am the Principal Investigator.

As a subcontractor to the Harvard School of Public Health, the University of Ibadan and University College Hospital in Ibadan, Nigeria

(i) assist in expanding antiretroviral therapy (ART) to low income HIV-infected persons in a manner that is consistent with national plans and policies; and

(j) develop sustainable indigenous capacity to continue these programs after the project ends.

This program provides support for infrastructural development and capacity strengthening for College of Medicine, University of Ibadan and University College Hospital Ibadan.

3. ExxonMobil Foundation 2006 – 2010 $1,000,000

Operation Stop Cervical Cancer in Nigeria

As a subcontractor with MD Anderson Cancer Center in Houston, Texas, I served as the Country Leader in implementing a cervical cancer screening and treatment program in Nigeria.

4. 1R01HD058359-01 05/01/2008 – 04/30/2013 Nigerian component = $247,000

HIV status and achieving fertility desires: Implications for HIV prevention and to help individuals and couples in African countries facing generalized HIV epidemics to achieve their family size goals while avoiding or coping with HIV infection. I am the Co-PI for the Nigerian arm of this International project.

5. HU-CFAR Feasibility Project 09/18/2009- 07/31/2010 $18,500.00

Prospective, observational study to evaluate the sensitivity of Lipoarabinomannan (LAM) in a pediatric population with known HIV-infection. I am the study co-PI

6. GSK-EPI-HPV-AWACC-109117 2009-2010 $15,000

African Women and Cervical Cancer Study (AWACC). To study Human papillomavirus (HPV) type distribution in adult African women with diagnosed invasive cervical cancer.

College of Medicine, University of Ibadan receives 10% Institutional Support from this grant. I was the Country Principal Investigator .

7. Guttmacher Institute-AB 350: 2010-2012 $350,000

New Abortion Study to develop an update on status of Unsafe Abortion in Nigeria

College of Medicine. I am the Principal Investigator

8. NIH: 1R24TW008878-01 – 2010 – 2015 $9,769.014.00

The NIH Medical Education Partnership Initiative in Nigeria (MEPIN) provides an opportunity to address many of the challenges facing the Nigerian education institutions today with the overall goal of improving and strengthening the medical

Publications

Dissertation and Thesis

"Organisational Structure of Trophoblastic Service in Nigeria" FMCOG dissertation, National Postgraduate Medical College.

ii. Books/Proceedings

1. Guidelines to Health Workers on HIV and AIDS in Nigeria. Nigerian Medical Association (NMA) Publications, March 1991.

2. Guidelines on appropriate use of Blood & Blood Products for Nigeria. The National Blood Transfusion service of the Federal Ministry of Health. August 18, 1991.

3. AdewoleIF. Abortion in Nigeria: A major Health Problem in Eliminating Unsafe Abortion in Nigeria. Proceedings of a Consultative Meeting. Nigerian Medical Association Ota, Nigeria. 16 - 17 August, 1991.

4. Adewole, IF.(1992). The role of Health Professional Associations in National Health Information System. Proceedings of the International Conference on the Nigerian Health Information System Abuja, Nigeria Feb 1992. Eds. Makanjuola JDA and Onibokun, AG, Federal Ministry of Health and Social Services, Lagos, Nigeria. Pp 202-203.

5. Adewole IF.Documenting the Abortion Problem in Nigeria. In Abortion Methodology Workshop. Proceedings of a Meeting organised by the Campaign Against Unwanted Pregnancy (CAUP) Ota, Nigeria. 22-24 July 1993.

6. Adewole IF. The Concept of Networking in Advocacy Campaign - An Overview. In Networking to Eliminate Unsafe Abortion in Nigeria. Proceedings of a Consultative Meeting Campaign Against Unwanted Pregnancy (CAUP) Lagos, Nigeria. 2-5 June, 1994.

7. Babarinsa IA, Adewole, IF, Ajayi AB (1994). Church-based Confinement Services in Ibadan, Nigeria, A Significant Factor in Maternal Mortality. In: Improving Reproductive Health in Africa. Eds Adewole IF, Babarinsa IA and Adekunle O.O. Proceedings of Confederation of African Medical Associations and Societies (CAMAS) 10th Congress Abidjan, Cote d'Ivoire 12-17 September 1994, Pp. 55-70.

8. Adewole, IF.(1994). Abortion and the Law in Africa. In: Improving Reproductive Health in Africa. Eds Adewole IF, Babarinsa IA and Adekunle O.O. Proceedings of Confederation of African Medical Association and Societies (CAMAS) 10th Congress, Abidjan, Cote d'Ivoire 12-17 September 1994. Pp. 151-159.

9. Adewole, IF. CAUP and Empowerment of Women In Empowering Women for Better Reproductive Health. Proceedings of a Consultative Meeting Campaign Against Unwanted Pregnancy (CAUP) Ota, Nigeria. 8-11 December, 1994.

10. Adewole, IF.(1995). The role of Abortion and Miscarriage in Maternal Mortality and Morbidity In Promotion Safe Motherhood at the Primary Health Care Level. Proceeding of a SOGON workshop 5-7 October 1995 Ed. VE. Aimakhu, Published by Unicef. Pp. 81-92.

11. Adewole IF,Babarinsa IA, Ayinde AE. (1996). Influence of Time and Marital Pattern on the development of Cervical intraepithelia Neoplasia (CIN). In 9th World Congress of Cervical Pathology & Colposcopy, Sydney, Australia Proceedings of Conference Ed., Channen W & Atkinson K: Monduzzi Editore 12-15 May 1996. Pp. 509-513.

12. Adewole, IF.& Onwudiegu U. Pregnancy, Births and abortion: In status of Adolescents and Young Adults in Nigeria. (eds.) Dare O.O., Isiugo - Abanihe I.M., Jimoh A, Omololu O & Udegbe I.B.) Chestrad 1997; 353 - 360.

13. Adewole IF. Epidemiology, Clinical Features and Management of Cervical Carcinoma. In: Contemporary Obstetrics and Gynaecology for developing Countries. Okonofua F. and Odunsi K eds, Women’s Health and Action Research Centre, Benin City,2003; Chapter 16:Pp 289-315

14. The Society of Gynaecology and Obstetrics of Nigeria (SOGON) 2005. Manual on the Management of HIV/AIDS in Pregnancy. ISBN 978-066-634-6 Pp 1-33

15. Federal Ministry of Health ( 2005) National Guidelines on the Prevention of Mother-To-Child Transmission of HIV(PMTCT) ISBN 978-166-412-6 Pp 1-78.

16. Adewole IF, Odutolu O, Sagay AS ( 2005). Prevention of Mother to Child Transmission of HIV. Eds: Adeyi O, Kanki PJ, Odutolu O and Idoko J In AIDS IN NIGERIA. Harvard University Press. Pp 178-203

17. Bankole A, Oye-Adeniran BA, Singh S, Adewole IF, Wulf D, Sedgh G and Hussain R (2006) Unwanted Pregnancy and Abortion in Nigeria: Causes and Consequences, New York: The Guttmacher Institute,

18. Ajuwon A, Owoaje E, Falaye F, Osinowo K, Aimakhu C, Adewole IF( 2007) Training manual on Sexual, Reproductive health and Rights and HIV prevention for Medical Students in Nigeria.ISBN:978-245-104-5.

19. Isaac Adewole and Solomon Sagay. Overview of Prevention of Mother-to-Child Transmission of HIV. In Grounds Up. Building Comprehensive HIV-AIDS Program in Resource limited settings. Eds RG Marlink & Sara J. Teitelman .Publisher Elizabeth Glaser Pediatric AIDs Foundation, 2008. Vol 2: Pp 717-738.

20. Akinwuntan AA and Adewole IF. Gestational Trophoblastic Diseases. In Fundamentals of Obstetrics and Gynaecology. Eds Ikpeze OC. Africana First Publishers Plc Pp233-255.2009.

21. AORTIC Africa Cancer Plan:2013-2017 Adewole IF, Denny L, Odedina F. Rebbeck ,Morhason-Bello IO. November 2013

22. Rebbeck T & Adewole IF. Research Dissemination. In Handbook of Cancer research in Africa.WHO-2013

iii. Articles in Learned Journals

Gynaecological Oncology:

23. Adewole, IF, Rustin, GJS, Newlands, ES, Dent, J. and Bagshawe, K.D. (1986). Fertility in Patients with Gestational Trophoblastic Tumours treated with Etoposide, Eur. J. Cancer Clin. Oncol. Vol. 22, (No. 12) 1479-1482.

24. Adewole, IF,and Newlands, ES, Lamki, H. and Nevin, M. (1987). Metastatic germ cell tumour associated with XY gonadal dysgenesis; successful chemotherapy. Case report. Br. J. Obstet. Gynae. vol. 94; 589-591.

25. Adewole, IF,and Newlands, ES. (1987). Neuron - specific Enolase (NSE) as a tumour maker, Comparative Evaluation with Carcino-Embryonic Antigen (CEA) as a marker of Small Cell Lung Cancer (SCLC). Med. Oncol. and Tumour Pharmacother. vol. 4, (No. 1); 11-15.

26. Adewole, IF,and Adeleye, JA. (1991). "Changing Parameters of Gestational Trophoblastic Disease in Nigeria". Improving the Outlook. Nig. J. Surg. Sciences. vol. 1, No. 1: 59-60.

27. Adewole, IF,(1991). An ELISA for Human Chorionic Gonadotrophin (HCG). Niger. Med. J. vol. 21, No. 6: 172-175.

28. Adewole, IF,Akang, EEU. Edozien, LC. (1993). Cervical Sarcoma: A Clinico-pathologic study of 6 cases. J. HK Med. Ass. (vol. 44, No. 4: 47-49.

29. Edozien, LC, & Adewole, IF. (1993). Cervical Carcinoma in Nigeria - A need for early detection. Afr. J. Med. & Med. Sci. vol. 22; No. 4: 87-92.

30. Omigbodun, AO, Thomas, JO, Adewole, IF, Ogunlusi, ML (1993). Triage of Patients with Abnormal Cervical Smears in the absence of Colposcopy. Tropical and Geographical Medicine. vol. 45; No. 4: 157-158.

31. Omigbodun, AO. Thomas, JO. Adewole, I.F. (1994). Cytologic Detection of Urinary-bladder involvement in cervical-cancer. Int. J. of Gynaec. Cancer. vol. 4, 401-403.

32. Adewole, I.F., Edozien LC, Babarinsa, IA, Akang, EEU. (1997) Invasive and In-Situ Carcinoma of the Cervix in young Nigerians. A Clinico-Pathologic Study of 27 Cases. Afr. J. Med. & Med. Sci. 26: 191 - 193.

33. Adewole, IF., Babarinsa, IA, Thomas J., Ajayi, AB. (1997) Ovarian Cancer Associated with Ovulation Induction Afr. J. Med. Sci. 26: 203-204.

34. Akang EEU, Adesina AO, Ilesanmi AO, Adewole, I.F. Pindiga UH (1997). Ovarian Teratomas in Ibadan, Nigeria. A clinico-pathologic study. Trop. J. Obstet. Gynae. vol. 14; No. 1: 34-37.

35. Ajayi IO. Adewole IF. (1998). Determinants of utilisation of cervical cancer screening facility in a low socio-economic setting in Nigeria. J. Obstet Gynae. vol. 18, No. 2: 154-158.

36. Ayinde AE, Adewole, IF. Babarinsa IA. (1998). Trends in Cervical Cancer screening in Ibadan, Nigeria. A four year review. W. Afr. J. Med. vol. 17; No. 1: 25-30.

37. Adewole IF, Babarinsa IA, Odeniyi GD. (1998). Cryotherapy in the management of cervical intraepithelial neoplasia in developing countries. Int. J. Gynaecol. Obstet. Vol. 60: 69-70.

38. Ajayi IO, Adewole IF, (1998) Knowledge and attitude of general outpatient attendants in Nigeria to cervical cancer. Cent. Afr. J. Med. Vol. 44, No. 2: 41-43.

39. Babarinsa IA. Akang EEU, Adewole IF. (1998). Pattern of Gynaecological Malignancies at the Ibadan cancer registry (1976-1995) Nig. Qt. J. Hosp. Med. vol. 8; No. 2: 103-106.

40. Babarinsa, IA, Adewole, IF (1998). Knowledge and Attitude to utilization of cervical cytology screening by female workers in a Nigerian Teaching Hospital. Nig. Med. Pract. Vol. 35; No. 3/4: 48-52.

41. Akang EEU, Adesina AO, Ilesanmi AO, Adewole, IF. Pindiga UH (1997). Ovarian Teratomas in Ibadan, Nigeria. A clinico-pathologic study. Trop. J. Obstet. Gynae. vol. 14; No. 1: 34-37.

42. Onoviran, OO, Dada YO, Adewole IF. (1998) Cervical cancer in Nigeria. DOKITA Vol. 25; No. 1: 72-77.

43. Babarinsa IA, Campbell, OB., Adewole IF. (1999) Pyometria complicating cancer of uterine cervix. Int. J. Gynecol. Obstet. Vol. 64: 75-76.

44. Fawole AO, Babarinsa IA, Ogunbiyi, JO, Familusi F, Adewole, IF. (1999). Sarcoma Botyroides in seven year old: Successful chemotherapeutic management. J. Obstet. Gynae. 1: 92-93.

45. Babarinsa IA, Fakokunde FA, Ogunbiyi JO, Adewole IF (1999) Vulval and Vaginal Cancer as seen at the University College Hospital, Ibadan, Nigeria. Afr. J Med Med Sci 28:77-80.

46. Campbell OB, Akinlade IB, Arowojolu AO, Babarinsa IA, Agwimah RI, Adewole IF (2000).Comparative Evaluation of Hypofractionated Radiotherapy and Conventional Fractionated Radiotherapy in the Management of Cancer of the Cervix in Ibadan, Nigeria. Afr. J. Med. & Med. Sc.29:253-258.

47. Adewole IF, Oladokun A, Fawole AO, Olawuyi JF, Adeleye JA (2000). Fertility regulatory methods and development of complications after evacuation of complete hydatidiform mole J. Obst. Gynaecol. l20:168-69.

48. Osamor JO, Oluwasola O, Adewole IF (2002) A clinico-pathological study of complete and partial hydatidiform moles in a Nigerian population. J. Obst. Gynaecol 22 (4) 423-425.

49. Ajayi IO, Adewole IF (2002) Breast and cervical cancer screening activities among family physicians in Nigeria. Afr. J. Med. Med. Sci. 31: 305-309.

50. Adesina AO, Babarinsa IA, Fawole A, Adeniji RA, Adewole IF (2003). Cervical cytology service in Nigeria: providers’ perspective. J. Obst. Gynaecol 23: 416-418.

51. Odukogbe AA, Adebamowo CA, Ola B, Olayemi O, Oladokun A, Adewole IF, Omigbodun OA, Aimakhu CO, Okunlola MA, Fakolujo O, Oluyemi FA (2004). Ovarian Cancer in Ibadan: Characteristics and management. J. Obst Gynaecol 24: 294-297.

52. Adewole IF, Benedet JL, Crain BT, Follen M (2005) Evolving a strategic approach to cervical cancer control in Africa. Gynecologic Oncology 99 :S209-S212

53. Odukogbe AA, Adebamowo CA, Adeniji AO, Omigbodun AO, Olayemi O, Oladokun A, Owolabi MS, Aimakhu C, Adewole IF, Owoaje E (2005). Total Ovulation period: any contribution to ovarian carcinogenesis? Afr. J. Med. Med Sci. 34: 307-8.

54. Roblyer D, Park S-U, Richards-Kortum R, Adewole IF, Follen M. (2007) Objective Screening for Cervical Cancer in Developing Nations: Lessons from Nigeria. Gynecologic Oncology, Volume 101, Issue 1, Supplement 1, October 2007.

55. Okafor C, Follen M, Adewole I. (2007). A comparative Overview of healthcare challenges for stakeholders and planners. Gynecologic Oncology, Volume 101, Issue 1, Supplement 1, October 2007.

56. Miller D, Okolo CA, Mirabal Y, Guillaud G, Arulogun OS, Oladepo O, Crain B, Follen M, Adewole IF (2007). Knowledge dissemination and evaluation in a Cervical Cancer Screening Implementation Program in Nigeria. Gynecologic Oncology, Volume 101, Issue 1, Supplement 1, October 2007.

57. Akinwuntan AL, Adesina AO, Okolo CA, Oluwasola OA, Oladokun OA, Ifemeje AA, Adewole IF.(2008). Correlation of cervical cytology and visual inspection with acetic acid in HIV positive women. Journal of Obstetrics and Gynaecology 28(6): 638-641.

58. Luciani S, Vardy L, Paci E, Adewole I, Sasco A, Calvacante T; Cancer prevention and population-based screening.ICCC-3 Session C Group.Tumori. 2009 Sep-Oct;95(5):597-609

59. Okolo Clement , Silvia Franceschi, Isaac Adewole, Jaiye O Thomas, Michele Follen, Peter JF Snijders, Chris JLM Meijer, Gary M Cliffordl. Human papillomavirus infection in women with and without cervical cancer in Ibadan, Nigeria. Infectious Agents and Cancer 2010, 5:24

60. Oladokun A, Morhason-Bello IO, Bello FA, Adewole IF.The learning curve of radical hysterectomy for cervical cancer in Ibadan. Afr J Med Med Sci 2010; 39: 329–32.

61. Bello FA, Enabor OO and Adewole IF.Human Papilloma Virus Vaccination for Control of Cervical Cancer: A Challenge for Developing Countries.Afr J Reprod Health 2011; 15[1http://www.ncbi.nlm.nih.gov/pubmed?term=Yamal%20JM%255BAuthor%255D&cauthor=true&cauthor_uid=22559693" style="box-sizing: border-box; background-color: transparent; color: rgb(51, 122, 183); text-decoration: none; line-height: inherit; outline: 0px;">Yamal JM, Zewdie GA, Cox DD, Atkinson EN, Cantor SB, MacAulay C, Davies K, Adewole I, Buys TP, Follen M. Accuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia without colposcopic tissue information; a step toward automation for low resource settings. J Biomed Opt. 2012 Apr;17(4):047002. doi: 10.1117/1.JBO.17.4.047002.

64. Cornet I, Gheit T, Franceschi S, Vignat J, Burk RD, Sylla BS, Tommasino M, Clifford GM; IARC HPV Variant Study Group. Human papillomavirus type 16 genetic variants: phylogeny and classification based on E6 and LCR.J Virol. 2012 Jun;86(12):6855-61. doi: 10.1128/JVI.00483-12. Epub 2012 Apr 4

65. Imran O Morhason-Bello, Folakemi Odedina, Timothy R Rebbeck, Joe Harford, Jean-Marie Dangou, Lynette Denny, Isaac F Adewole. Challenges and opportunities in cancer control in Africa:?a perspective from the African Organisation for Research and Training in Cancer. Lancet Oncol 2013; 14: e142–51

66. Megan O’Brien, Faith Mwangi-Powell, Isaac F Adewole, Olaitan Soyannwo, Jacinto Amandua, Elizabeth Ogaja, Mary Okpeseyi, Zipporah Ali, Rose Kiwanuka, Anne Merriman. Improving access to analgesic drugs for patients with cancer in sub-Saharan Africa.Lancet Oncol 2013; 14: e176–82

67. Daniela Cristina Stefan, Ahmed M Elzawawy, Hussein M Khaled, Fabien Ntaganda, Anita Asiimwe, Beatrice Wiafe Addai, Seth Wiafe, Isaac F Adewole.Developing cancer control plans in Africa: examples fromfive countries. Lancet Oncol 2013; 14: e189–95

68. Morhson-Bello IO, Adesina OA, Adedokun BO, Awolude O, Okolo CA, Aimakhu CO, Ainwunmi BO, Oladokun A, Adewole IF. Knowledge of the human papilloma virus vaccines, and opinions of gynaecologists on its implementation in Nigeria.Afr J Reprod Health. 2013 Jun;17(2):150-6

69. Denny L, Adewole I, Anorlu R, Dreyer G, Moodley M, Smith T, Snyman L, Wiredu E, Molijn A, Quint W, Ramakrishnan G, Schmidt J.Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa.Int J Cancer. 2013 Aug 9. doi: 10.1002/ijc.28425. [Epub ahead of printhttp://www.ncbi.nlm.nih.gov/pubmed/24331750" style="box-sizing: border-box; background-color: transparent; color: rgb(51, 122, 183); text-decoration: none; line-height: inherit; outline: 0px;">Recommendations for cervical cancer prevention in sub-saharan Africa. Vaccine. 2013 Dec 29;31 Suppl 5:F73-4.

73. Adewole I.F. Cancer Control in Africa: Options for a Vulnerable Continent. World cancer report 2014/ edited by Bernard W. Stewart and Christopher P. Wild Pp 750-1

Abortion/Reproductive Tract Infection/ HIV-AIDS:

74. Adelusi, B, Adetoro, OO, Adewole, IF, Osoba, AO. (1987). Epidemiology of Acute Pelvic InflammatoryDiseases in a female population attending an STD Clinic in Ibadan. Afr. J. Std. vol. 3, No. 1: 9-11.

75. Adewoe, IF.(1991). An exploratory study of knowledge of AIDS and HIV infection among Health Professionals in Nigeria. Niger Med. J. vol. 21; No. 5: 150-152.

76. Adewole, IF. (1992). Trends in Post Abortal mortality and morbidity in Nigeria. Int. J. Gynae. & Obst. Vol. 38: 115-118.

77. Adewole, IF.1993/94. That Our Women may Live. The Nigerian Family Practice vol. 3; No. 2: 9-11.

78. Adewole, IF.Fawole AO, Babarinsa IA, Oni AA. (1997). The value of antenatal screening for syphilis in Ibadan. Nig. Med. Pract. vol. 34: 39-42.

79. Oladimeji AO, Ayuba TT, Adewole, IF, Babarinsa IA, Bakare RA (1998). Clinico-Pathologic Study of vaginal discharge in Ibadan. Nig. Qt. J. Hosp Med. vol. 8, No. 1, 6-8.

80. Henshaw, S.K., Singh Susheela, Oye-Adeniran, BA, Adewole, IF, Iwere, N, Cuca Yvete, P. (1998), Incidence of Induced Abortion in Nigeria. Int. Fam. Plann. Perspect. 24:156-164.

81.IF, Odeniyi GD, Fashina NA, Ogunbiyi, JO. (1998). The relative value of Bacteriology and Cytology in the diagnosis of Sexually Transmitted Diseases. Nig. Qt. J. of Hosp. Med. Vol. 8 (No. 3) 170 - 172.

82. Oni, AA, Ogundiran, Niyi, Bakare RA, Adewole IF, Olumide, SK, Tomori, BB, Oyediji, K. (1999). The role of a secondary health centre in the Management of sexually transmitted diseases in Nigeria. Nig. Med. Pract. Nig. Med. Pract. Vol. 37 No. 3/4.

83. Adewole IF, Oye-Adeniran BA, Iwere I, Oladokun A, Gbadegesin A. (2002) Terminating an unwanted pregnancy in Nigeria – the economic implications in Nigeria. J. Obst. Gynaecol 22(4) 437-438.

84. Adewole IF, Oye-Adeniran BA, Iwere I, Oladokun A, Gbadegesin A, Babarinsa IA (2002) Contraceptive usage among abortion Seekers in Nigeria. W. Afr. J. Med 21 (2) 112-114.

85. Bakare RA, Oni AA, Umar US, Adewole IF, Shokunbi WA, Fayemiwo SA. Fasina NA. (2002) Pattern of Sexually Transmitted Diseases among Commercial Sex Workers (CSWs) in Ibadan. Afr. J. Med. Med. Sci. 31: 243-247

86. Oye-Adeniran BA, Adewole IF, Umoh AV, Iwere N, Dipeolu O & Obilade TT( 2003) Contraceptive Prevalence at the Community level in South- Western Nigeria. Nig Qt J Hosp Med 13(3-4) 49-53.

87. Oye-Adeniran BA, Adewole IF, Umoh AV, Fapounda OR, Iwere N. Characteristics of Abortion Seekers in South-Western Nigeria. Afr J Repr Health. 2004.

88. Oye-Adeniran BA, Adewole IF, Iwere N, Mahmoud P. (2004). Promoting Sexual and Reproductive Health and Rights in Nigeria through change in Medical School Curriculum. Afr J Repr Hlth. 8: 85-91.

89. Adewole I, Jegede A, Adesina A, Bamgboye A, Adejumo P, Smart P, Adegbola M, Sankale J, Kanki P.(2004) Male responsibilities in the prevention of mother to child transmission of HIV in Nigeria. Medimond International Proceedings XV International AIDS Conference, Bangkok, Thailand. 11-16 July: Pp 107-111

90. Adewole I, Osowole O, Aborkor L, Adesina A, Sankale J, Kanki P.(2004) Opinion Leaders Awareness and Perception of Mother to Child Prevention of Mother to Child Transmission of HIV in Nigeria. Medimond International Proceedings of XV International AIDS Conference, Bangkok, Thailand. 11-16 July: Pp 411-415

91. Adewole I,Adesina A., Onibokun A. Adebusuyi A, Kayode A, Osofisan E, Fawemida A, Sankale J, Kanki P.(2004). Evaluation of VCT in a Nigerian PMTCT Service Delivery Unit. Medimond International Proceedings of XV International AIDS Conference, Bangkok, Thailand. 11-16 July: Pp 25-29.

92. Adewole I, Jegede A, Adesina A, Bamgboye A, Adejumo P, Smart P, Adegbola M, Sankale J, Kanki P.(2004) Cultural Context of Mother to Child Transmission of HIV in Nigeria. Medimond International Proceedings of XV International AIDS Conference, Bangkok, Thailand. 11-16 July: Pp 213-217.

93. Adewole I, Jegede A, Adesina A, Bamgboye A, Adejumo P, Smart P, Adegbola M, Sankale P, Kanki P(2004).The Role of Significant Others in the Management of Discordant Couples. Medimond International Proceedings of XV International AIDS Conference, Bangkok, Thailand. 11-16 July. Pp 103-117.

94. Okwoli NR, Adetosoye AI, Adewole IF (2004). The Gram Stain Smear: A screening test for genital mycoplasmas from vaginal specimens prior to culture. J. Biomedical Investigation 2004; 2 (1): 26-30.

95. Oye-Adeniran BA, Adewole IF, Long CM. (2004). Advocacy for Reform of the Abortion Law in Nigeria. Repr. Health Matters 12 (24Suppl) 207-219.

96. Oye-Adeniran BA, Adewole IF, Umoh AV, Iwere N, Gbadegesin A. (2005). Induced Abortion in Nigeria: Findings from Focus Group Discussion Studies. Afr J Repr Health. 9(1): 133-141.

97. Oye-Adeniran BA, Adewole IF, Odeyemi KA, Ekanem EE, Umoh AV. (2005) Contraceptive prevalence among young women in Nigeria. J. Obstetric Gynaecol;25 (2): 183-185.

98. Oye-Adeniran BA., Adewole IF, Umoh AV, Oladokun A, Gbadegesin A, Odeyemi KA, Ekanem EE (2005) Sources of Contraceptive Commodities for Users in Nigeria. PLoS Med 2(11) e306.

99. Oye-Adeniran Boniface A, Adewole Isaac F, Gbadegesin Abidoye, Umoh Augustine V, Oladokun Adesina, Yusuf Bidemi, Osilaja Oluwaseun K (2006) The Characteristics of Contraceptive Users in Nigeria. Sexual Health Matters. 7(2) :48-53

100. Agbakoba NR, Adetosoye AI, Adewole IF (2006). Biochemical and serologicalcharacterization of mycoplasma strains isolated from the genital tract of humans in Nigeria. Afr J Med Med Sci; 35(2):b125-9.

101. Sedgh Gilda, Bankole Akinrinola, Oye-Adeniran Boniface, Adewole Isaac F, Singh Susheela, Hussain Rubina ( 2006) Unwanted Pregnancy and Associated Factors Among Nigerian Women. International Family Planning Perspectives. 32( 4) :175-184.

102. Oye-Adeniran BA, Adewole IF, Umoh VA, Oladokun A, Gbadegesin A, Ekanem EE, Yusuf B, Odeyemi KA, Iwere N, Mahmoud P (2006) Community-based study of Contraceptive behaviour in Nigeria. Afr J. Rep Health 10(2):90-104.

103. Agbakoba NR, Adetosoye AI, Alaka OO, Adewole IF.(2006) Colonization of MouseReproductive Organs Following Vaginal Inoculation with Human Ureaplasma: Effect on Fertility. World Journal of Medical Sciences 1 (2): 140-143

104. Oye-Adeniran Boniface A, Adewole Isaac F, Oduyebo Oyin, Ekanem E.Ekanem, Umoh Augustine V. (2006) A study of sexual behaviour among Nigerian Women. Women’s Sexual Health Journal IX: 5-16.

105. Bankole A, Sedgh A, Oye-Adeniran BA. Adewole IF, Hussain R, Singh S (2007). Abortion seeking behavior among Nigerian Women.J. biosoc. Sci, Pp 1-22.

106. Arulogun OS, Adewole IF, Olayinka-Alli l, Adesina AO (2007). Community Gate Keepers’ Awareness and Perception of Mother to –Child Transmission of HIV services in Ibadan, Nigeria. African Journal of Reproductive Health 11(1) 67-75

107. Agbakoba NR, Adetosoye AI, Adewole IF (2007). Presence of Mycoplasma and Ureaplasma Species in the vagina of Women of Reproductive Age. West Afr. J. of Medicine; 26(1): 28-31.

108. Henshaw Stanley K., Adewole Isaac, Singh Susheela, Bankole Akinrinola, Oye-Adeniran Boniface Hussain and Rubina (2008). Severity and Cost of Unsafe Abortion Complications Treated in Nigerian Hospitals. International Family Planning Perspectives, 2008, 34(1):40–50.

109. Obajimi Millicent O, Atalabi Mojisola O, Ogbole Godwin I, Adeniji-Sofoluwe Adenike T, Agunloye Atinuke M, Adekanmi Ademola J,Osuagwu Yvonne U,Olarinoye Sefiat A,Olusola-Bello Mojisola A,Ogunseyinde Ayotunde O,Aken'Ova Yetunde A, Adewole Isaac F (2008) . Abdominal ultrasonography in HIV/AIDS patients in southwestern Nigeria .BMC Med Imaging.8: 5.

110. JA Otegbayo; BO Taiwo; TS Akingbola; GN Odaibo;KS Adedapo;S Penugonda; IF Adewole;DO Olaleye;R Murphy;P Kanki. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.Annals of Hepatology 2008; 7(2):161-165.

111. Adewole F. Isaac, Orji C. Nnenna, Oye-Adeniran A. Boniface. Unsafe Abortion and Development: A Strategic Approach.IDS Bulletin, Vol. 39, No. 3. (July 2008), pp. 47-54.

112. Agbakoba NR, Adetosoye AI, Adesina OA, Adewole IF (2008). Polymerase chain reaction assay of Ureaplasma strains isolated from high vaginal swabs of women in Ibadan. Afr.J.Med. Med. Sci. 37: 249-251.

113. Agbakoba NR, Adetosoye AI, Adewole IF, Chukwuma CM (2008) Isolation of vaginal pathogens along with genital mycoplasmas from asymptomatic gynaecology and antenatal clinic attendees. American-Eurasian Journal of Scientific Research 3(2):249-254

114. OJESINA Akinyemi I, CHAPLIN Beth, SANKALE Jean-Louis^, MURPHY Robert^, IDIGBE Emmanuel^, ADEWOLE Isaac, EKONG Ernest^,IDOKO John^, KANKI Phyllis (2008) Interplay of Reverse Transcriptase Inhibitor Therapy and Gag p6 Diversity in HIV Type 1 Subtype G and CRF02_AG. AIDS research and human retroviruses; 24:1167-1174.

115. Awolude OA,Adesina OA, Oladokun A, Adewole IF (2009) Emergency Obstetric Patients in Developing Countries and Prevalence of HIV Infection. Afr. J. Med. Med. Sci. 38:39-41.

116. Hawkins CA, Chaplin B, Idoko J, Ekong E, Adewole I, Gashau W, Murphy RL Kanki P (2009) Clinical and Genotypic Findings in HIV-Infected Patients with the K65R Mutation Failing First-Line Antiretroviral Therapy in Nigeria. J. Acquir Immune Defic Syndr 52(2): 228-234.

117. Cadmus SI, Jenkins AO, Godfroid J, Osinusi K, Adewole IF, Murphy RL, Taiwo BO. Mycobacterium tuberculosis and Mycobacterium africanum in stools from children attending an immunization clinic in Ibadan, Nigeria. Int J Infect Dis 2009 Jan 31 [Epub ahead of printhttp://www.ncbi.nlm.nih.gov/pubmed/20964479" style="box-sizing: border-box; background-color: transparent; color: rgb(51, 122, 183); text-decoration: none; line-height: inherit; outline: 0px;">Impact of HIV type 1 subtype on drug resistance mutations in Nigerian patients failing first-line therapy.AIDS Res Hum Retroviruses. 2011 Jan;27(1):71-80

121. Fatai A. Fehintola, Olusegun O. Akinyinka, Isaac F. Adewole, Chedza C. Maponga, Qing Ma and Gene D. Morse. Drug Interactions in the Treatment and Chemoprophylaxis of Malaria in HIV Infected Individuals in Sub Saharan Africa.Current Drug Metabolism, 2011, 12, 51-56

122. Agbakoba NR, Adetosoye AI, Adewole IF, Obi CM, Enemuor SC (2011) Prevalence of Genital Mycoplasmas in Women of Various Socio-Economic Status.International Journal of Microbiological Research 2(2): 162-166

123. Brown, Biobele J., Oladokun, Regina E. , Osinusi, Kikelomo , Ochigbo, Sunny , Adewole, Isaac F. and Kanki, Phyllis. 'Disclosure of HIV status to infected children in a Nigerian HIV Care Programme', AIDS Care, AIDS Care. 2011, 1-6, iFirst

124. Fehintola FA, Akinyinka OO, Adewole IF, Maponga CC, Ma Q, Morse GD.Drug interactions in the treatment and chemoprophylaxis of malaria in HIV infected individuals in sub Saharan Africa.Curr Drug Metab. 2011 Jan;12(1):51-6

125. Jesse Abiodun Otegbayo, Titilola Stella Akingbola, Joshua Odunayo Akinyemi,Kayode Solomon Adedapo, Georgina Njideka Odaibo, Yetunde Adebisi Aken Óva,David Olufemi Olaleye, Isaac Folorunsho Adewole, Robert Murphy, Phylis Kanki (2011)Immunovirological and Biochemical Changes in Nigerian Patients with Hepatitis B Coinfection on Antiretroviral Therapy.World Journal of AIDS, 2011, 1, 31-36

126. Adesina, O; Oladokun, A; Akinyemi, O; Akingbola, T; Awolude, O; Adewole, I Risk of anaemia in HIV positive pregnant women in Ibadan, south west Nigeria.Afr J Med Med Sci 40, 670 (2011).

127. Fehintola FA, Scarsi KK, Ma Q, Parikh S, Morse GD, Taiwo B, Akinola IT, Adewole IF, Lindegardh N, Phakderaj A, Ojengbede O, Murphy RL, Akinyinka OO, Aweeka FT. Nevirapine-Based Antiretroviral Therapy Impacts Artesunate and Dihydroartemisinin Disposition in HIV-Infected Nigerian Adults.AIDS Res Treat. 2012;2012:703604. doi: 10.1155/2012/703604. Epub 2012 Mar 5

128. SA Olowookereand IF Adewole. Socio-demographic characteristics and challenges experienced bydisabled patients living with HIV/AIDS in a tertiary hospital in Ibadan, Nigeria.Afr. J. Med. med. Sci. (2012) 41

129. Samuel Anu Olowookere, Akinola Ayoola Fatiregun, Isaac F. Adewole Knowledge and attitudes regarding HIV/AIDS and antiretroviral therapy among patients at a Nigerian treatment clinic J Infect Dev Ctries 2012; 6(11):809-816.

130. Kavanaugh ML, Moore AM, Akinyemi O, Adewole I, Dzekedzeke K, Awolude O, Arulogun O. Community attitudes towards childbearing and abortion among HIV-positive women in Nigeria and Zambia. Cult Health Sex. 2013;15(2):160-74.

131. Falade CO, Adesina-Adewole B, Dada-Adegbola HO, Ajayi IO, Akinyemi JO, Ademowo OG, Adewole IF, Kanki P. Evaluation of Paracheck-Pf(TM) rapid malaria diagnostic test for the diagnosis of malaria among HIV-positive patients in Ibadan, south-western Nigeria Pathog Glob Health. 2013 Mar;107(2):69-77.

132. Adetunji AA, Achenbach C, Feinglass J, Darin KM, Scarsi KK, Ekong E, Taiwo BO, Adewole IF, Murphy R. Optimizing treatment switch for virologic failure during first-line antiretroviral therapy in resource-limited settings.J Int Assoc Provid AIDS Care. 2013 Jul-Aug;12(4):236-40.

133. Bankole A, Biddlecom AE, Dzekedzeke K, Akinyemi JO, Awolude O, Adewole IF.Does knowledge about Antiretroviral Therapy and Mother to Child Transmission affect the relationship between HIV Status and Fertility Preferences and Contraceptive use? New Evidence from Nigeria and Zambia. J Biosoc Sci. 2013 Dec 16:1-20. [Epub ahead of print http://www.ncbi.nlm.nih.gov/pubmed/24446424" style="box-sizing: border-box; background-color: transparent; color: rgb(51, 122, 183); text-decoration: none; line-height: inherit; outline: 0px;">Disposition of amodiaquine and desethylamodiaquine in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapy.J Antimicrob Chemother. 2014 Jan 19.

General Gynaecology:

1. Adewole, I.F.(1994). A case of cyclical menouria syndrome. Afr. J. Med. and Med. Sci. vol. 23: 9 - 11.

2. Adewole, I.F.Thompson EF, Babarinsa IA, Akang EEU (1997). The Value of Routine Endometrial Biopsy in Gynaecological Practice. W. Afr. J. Med. vol. 16; No. 4: 242-245.

3. Babarinsa IA, Ajayi, AB, Adewole, I.F., Adeleye, JA (1997). Day-care Diagnostic Laparoscopy; experience with the first 1000 patients in a Tropical Gynaecological Service. Gynaecological Endoscopy vol. 6; 273-276.

4. Ajayi AB., Babarinsa I.A. Adewole IF (1998). Day-care Diagnostic Laparoscopy in Infertility Evaluation. Nig. Qt. J. Hosp. Med. Vol. 8 (4) 288-290.

5. Olaore JA, Shittu L, Adewole IF (1999). Intravesical Lippes Loop following insertion for the treatment of Asherman's syndrome: A case report. Afr. J. Med & Med Sci. 28 : 207-208.

6. Odukogbe AA, Onifade RA, Adewole IF, Adesina AO, Awolude OA (2001) Recto-vaginal and vesico-vaginal communications following coital injury. J. Obst. Gynaec. 21 : 315-316.

7. Oladokun A, Babarinsa IA, Adewole IF. (2002) The deficient Perineum - Oblique presentation of a clinically obvious anomaly. Trop.J.Obs.Gynae.31: 267-269.

Miscellaneous:

8. I.F.(1991). Effective Communication and Medical Practice. Niger. Med. J. Vol. 21; No. 21: 59-60.

9. Ogunbiyi AO, Adewole IF, Ogunleye O, Ogunbiyi JO, Ogunseinde, OO, Baiyeroju-Agbeja A. (2003) Focal dermal hypoplasia: a case report and review of literature. W. Afr J Med 22:346-349.

10. The International HapMap Consortium. Integrating Ethics and Science in the International HapMap Project. Nature Review Genetics.2004; 5:467-475.

11. Olapade-Olaopa EO, Alonge TO, Amanor-Boadu SD, Sanusi AA, Alese Ob, Omisanjo OO, Adeyinka AO, Sanya AO, Ogunbunmi P, Adewole IF (2005).On-site physicians at major sporting event in Nigeria. Pre- hospital and Disaster Medicine. 21(1): 40-45.

12. The International Hapmap Consortium (2005). A haplotype map of the human genome. Nature 437:1299-1320.

13. Pardis C. Sabeti, Patrick Varilly, Ben Fry, Jason Lohmueller¹, Elizabeth Hostetter, Chris Cotsapas, Xiaohui Xie, Elizabeth H. Byrne, Steven A. McCarroll, Rachelle Gaudet, Stephen F. Schaffner, Eric S. Lander & The International HapMap Consortium.Genome-wide detection and characterization of positive selection in human populations.Nature 449, 913-918 (18 October 2007).

14. International HapMap Consortium.A second generation human haplotype map of over 3.1 million SNPs.Nature 449, 851-861 (18 October 2007).

15. Eyelade OR, Akinyemi JO, Adewole IF. Patient’s perception and knowledge of anaesthesia and anaesthetists – a questionnaire survey. S. Afr. J. Anaesthesiol Analg 2010; 16 (4); 28-31

Contact Information

Phone: 08033299153	Address:	Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Facebook: Profile Link	LinkedIn: Profile Link	Twitter: Profile Link
Instagram: Profile Link	YouTube: Profile Link	Pinterest: Profile Link

Prof. Isaac F. ADEWOLE

Basic Information

`Resume`

Researches

Search Activities

Publications

Contact Information

CoMUI INDUCTS BACHELOR OF MEDICAL LABORATORY SCIENCE (BMLS) GRADUATING CLASS OF 2024

VALEDICTORY PROGRAMME & LECTURE IN HONOR OF PROFESSOR ADERONKE O. AKINPELU

CoMUI HOLDS COMMUNITY ENGAGEMENT WITH THE NEW UNIVERSITY OF IBADAN PRO-CHANCELLOR

APPRECIATION FOR BENEFACTION

IBADAN MEDICAL SPECIALISTS GROUP - UNITED KINGDOM (IMSG -UK) DONATES SOLAR ENERGY TO DEPARTMENT OF ANATOMY, COLLEGE OF MEDICINE, UNIVERSITY OF IBADAN

Dame Dr. ADAMITO OLUREMI IYUN @ 80!

ICOMAA-NA MEETS WITH COMUI PROVOST PROFESSOR T.O. OGUNDIRAN

APPOINTMENT OF PROFESSOR OYEDUNNI S. ARULOGUN AS THE VICE CHANCELLOR, CHRISLAND UNIVERSITY, ABEOKUTA, OGUN STATE

DEPUTY PROVOST, COLLEGE OF MEDICINE, UNIVERSITY OF IBADAN, IBADAN

CoMUI Provost Commends UIMSA for Outstanding Performance at NiMSA Southwest Convention and Sports Competitions

Quick Links

Get In Touch

Prof. Isaac F. ADEWOLE

Search Activities

Quick Links

Social Links

Get In Touch